Literature DB >> 24715746

Implementation of pharmacist-managed anticoagulation clinic in a saudi arabian health center.

Jean G Dib1, Khurram Mohammed2, Hisham I Momattin3, Ali M Alshehri4.   

Abstract

BACKGROUND: During the past 2 decades, a paradigm shift in the management of oral anticoagulation therapy has occurred. A multidisciplinary approach has been used and has proved beneficial from both a cost and quality perspective. However, this approach to anticoagulation therapy is not well established in Saudi Arabia and the Middle East, and the traditional way of managing anticoagulation patients is still the mainstay of care. The Pharmacy Services Division (PSD) in collaboration with physician, nursing, and medical support enterprises at the Dhahran Health Center established the pharmacy-managed anticoagulation clinic (ACC).
OBJECTIVE: To describe the implementation process of the first pharmacist-managed anticoagulation clinic in the eastern province of Saudi Arabia and its impact on patient care.
METHODS: The PSD in collaboration with medical staff successfully created a care delivery model utilizing clinical pharmacists' expertise to provide comprehensive anticoagulation management services at Saudi Aramco Medical Services Organization (SAMSO). Planning included analyzing existing practices, reviewing the relevant literature, obtaining physician input, formulating a business proposal, and developing clinical protocols and guidelines. Collaborative relationships were established with the center laboratory, scheduling services, and nursing and medical departments. Clinic services include patient assessment, anticoagulation monitoring, warfarin dosage adjustment, medication dispensing at the clinic, patient education, and feedback to referring physicians. Data (2 years before and after clinic inception) for all patients enrolled at the anticoagulation clinic were reviewed to evaluate the impact of the clinic on anticoagulation management, adverse events, and patient satisfaction.
RESULTS: A total of 578 patients were enrolled in the ACC. The total percentage of international normalized ratio (INR) within the target range was 59% versus 48% when compared to the previous traditional practice. The number of INR tests per patient dropped by 19%. Minor and major adverse events occurred in 10% and 1.5% of patients, respectively. Overall, the patients were very satisfied with the new clinic compared to the previous practice.
CONCLUSION: Implementation of the pharmacist-managed ACC in the eastern province of Saudi Arabia had a positive impact on patient care based on the improvements in the number of patients whose INR was within therapeutic range and patient satisfaction scores.

Entities:  

Keywords:  INR; ambulatory care; anticoagulation; pharmacist-managed clinic; warfarin

Year:  2014        PMID: 24715746      PMCID: PMC3971112          DOI: 10.1310/hpj4903-260

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  21 in total

1.  A pharmacist-managed anticoagulation clinic: six-year assessment of patient outcomes.

Authors:  Michelle L Willey; Larisa Chagan; Thomas S Sisca; Kevin J Chapple; A Kevin Callahan; Judy L Crain; Larissa E Kitenko; Theresa Martin; Kimberly D Spedden
Journal:  Am J Health Syst Pharm       Date:  2003-05-15       Impact factor: 2.637

2.  Comparison of two different models of anticoagulation management services with usual medical care.

Authors:  Kelly M Rudd; John G Dier
Journal:  Pharmacotherapy       Date:  2010-04       Impact factor: 4.705

3.  Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Jack Hirsh; Gordon Guyatt; Gregory W Albers; Robert Harrington; Holger J Schünemann
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

4.  Effect of a pharmacist-managed anticoagulation clinic on warfarin-related hospital readmissions.

Authors:  Y P Lee; J C Schommer
Journal:  Am J Health Syst Pharm       Date:  1996-07-01       Impact factor: 2.637

5.  Management of Chinese patients on warfarin therapy in two models of anticoagulation service - a prospective randomized trial.

Authors:  Fredric W H Chan; Raymond S M Wong; Wing-Hung Lau; Thomas Y K Chan; Gregory Cheng; Joyce H S You
Journal:  Br J Clin Pharmacol       Date:  2006-11       Impact factor: 4.335

6.  Aiming for safe anticoagulation.

Authors:  S D Fihn
Journal:  N Engl J Med       Date:  1995-07-06       Impact factor: 91.245

Review 7.  Systematic overview of warfarin and its drug and food interactions.

Authors:  Anne M Holbrook; Jennifer A Pereira; Renee Labiris; Heather McDonald; James D Douketis; Mark Crowther; Philip S Wells
Journal:  Arch Intern Med       Date:  2005-05-23

8.  Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs.

Authors:  E Chiquette; M G Amato; H I Bussey
Journal:  Arch Intern Med       Date:  1998 Aug 10-24

9.  Comparison of anticoagulant control among patients attending general practice and a hospital anticoagulant clinic.

Authors:  J P Pell; B McIver; P Stuart; D N Malone; J Alcock
Journal:  Br J Gen Pract       Date:  1993-04       Impact factor: 5.386

10.  Evaluation of 4 years of clinical pharmacist anticoagulation case management in a rural, private physician office.

Authors:  Michael E Ernst; Kim B Brandt
Journal:  J Am Pharm Assoc (2003)       Date:  2003 Sep-Oct
View more
  9 in total

1.  Validation of knowledge and adherence assessment tools among patients on warfarin therapy in a Saudi hospital anticoagulant clinic.

Authors:  Sireen Abdul Rahim Shilbayeh; Wejdan Ali Almutairi; Sarah Ahmed Alyahya; Nouf Hayef Alshammari; Eiad Shaheen; Alya Adam
Journal:  Int J Clin Pharm       Date:  2017-11-30

2.  Time in therapeutic range as a marker for thrombotic and bleeding outcomes in Fontan patients.

Authors:  Jenna M Faircloth; Kristin M Miner; Tarek Alsaied; Nicole Nelson; Julie Ciambarella; Tomoyuki Mizuno; Joseph S Palumbo; Alexander A Vinks; Gruschen R Veldtman
Journal:  J Thromb Thrombolysis       Date:  2017-07       Impact factor: 2.300

3.  Pharmacists' warfarin therapy knowledge and counseling practices in the Eastern Province, Saudi Arabia: A cross-sectional study.

Authors:  Ahmed Adel Mohamed; Marwah E Alnewais; Yasir A Ibrahim; Mohammad F Zaitoun
Journal:  J Pharm Bioallied Sci       Date:  2020-07-18

Review 4.  Medication Safety Systems and the Important Role of Pharmacists.

Authors:  Jeannell M Mansur
Journal:  Drugs Aging       Date:  2016-03       Impact factor: 3.923

5.  The Impact of a Pharmacist-led Warfarin Educational Video in a Saudi Setting.

Authors:  Sireen Abdul Rahim Shilbayeh
Journal:  J Pharm Bioallied Sci       Date:  2020-10-08

6.  Evaluation of a pharmacist vs. Haematologist-managed anticoagulation clinic: A retrospective cohort study.

Authors:  Afnan Noor; Mansoor A Khan; Ashraf Warsi; Mohammed Aseeri; Sherine Ismail
Journal:  Saudi Pharm J       Date:  2021-08-30       Impact factor: 4.330

7.  Pharmacy practice in hospital settings in GCC countries: Prescribing and transcribing.

Authors:  Ahmed H Al-Jedai; Fowad Khurshid; Ahmed Y Mayet; Hussain A Al-Omar; Sarah S Alghanem; Mohammed S Alsultan
Journal:  Saudi Pharm J       Date:  2021-07-21       Impact factor: 4.330

8.  Cost-Effectiveness of the Pharmacist-Managed Warfarin Therapy vs. Standard Care for Patients With Mechanical Mitral Valve Prostheses: An Egyptian Healthcare Perspective.

Authors:  Radwa Ahmed Batran; Nagwa Ali Sabri; Ihab Ali; Sarah Farid Fahmy
Journal:  Front Cardiovasc Med       Date:  2022-07-13

Review 9.  Pharmacist-managed clinics for patient education and counseling in Japan: current status and future perspectives.

Authors:  Kiyofumi Yamada; Toshitaka Nabeshima
Journal:  J Pharm Health Care Sci       Date:  2015-01-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.